Antibe Therapeutics Inc.

(ATE:PUR)

By |

Profile

Antibe Therapeutics Inc is a healthcare company. It is engaged in the development of patents and out-licensing of improved compounds of existing drugs. Its product includes ATB-346 a hydrogen sulfide-releasing derivative of naproxen. The company has two primary business segments: Antibe Therapeutics, a pharmaceutical development company, and Citagenix, a marketer and distributor of regenerative medicines serving the dental and orthopedic marketplaces.

Contact Information

Website: www.antibethera.com
Main Phone: +1 905 570-5103
Address: 15 Prince Arthur Avenue
State: ON
City / Town: Toronto
Country: CAN
Postal Code: M5R 1B2

Issuer Information

Exchange: CDX
CEO: Daniel Legault
Employees: 37
NAICS: Pharmaceutical Preparation Manufacturing(325412)
$ 0.24 $ 0. (0.00%)
Last Price 0.24 Change $ 0. Change % 0.00 Tick N/A
Bid N/A Bid Size 0.00 Ask N/A Ask Size 0.00
Open N/A High N/A Low N/A Prev Close 0.24
Last Trade Volume 0 52 Wk Hi 0.61 52 Wk Low 0.18
Market Cap 51.6 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 214,905,232.00 EPS (TTM) -0.05 PE Ratio N/A Exchange TSXV
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 1.8 1.8 1.8 1.8
Low Target Price Estimate 1.8 1.8 1.8 1.8
Mean Target Price Estimate 1.8 1.8 1.8 1.8
Standard Deviation 0 0 0 0
Date of Most Recent Estimate 04/06/18 04/06/18 04/06/18 04/06/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 0 0 0 1
Moderate Buy 0 0 0 0
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 0 0 0 1